# Southern First Bancshares Inc: overview

SFST · Nasdaq · CIK 1090009 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sfst.md) · [Financials](/companies/sfst/financials.md) · [Filings](/companies/sfst/filings.md) · [Insiders](/companies/sfst/insiders.md)

Latest reported revenue: [$1.3m](/filings/0001206774-26-000404.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 3, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001206774-26-000404).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.4](/filings/0001206774-25-000738.md) | [1.0 d](/filings/0001206774-26-000084.md) | [1.4](/filings/0001206774-26-000259.md) | [1.6](/filings/0001206774-26-000404.md) | [1.6](/filings/0001206774-25-000738.md) | [1.7 d](/filings/0001206774-26-000084.md) | [1.5](/filings/0001206774-26-000259.md) | [1.3](/filings/0001206774-26-000404.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [302.4%](/filings/0001206774-25-000738.md) | [549.5% d](/filings/0001206774-26-000084.md) | [369.8%](/filings/0001206774-26-000259.md) | [419.4%](/filings/0001206774-26-000404.md) | [541.4%](/filings/0001206774-25-000738.md) | [583.6% d](/filings/0001206774-26-000084.md) | [662.2%](/filings/0001206774-26-000259.md) | [846.2%](/filings/0001206774-26-000404.md) |
| Diluted EPS | $ per share | [0.54](/filings/0001206774-25-000738.md) | not reported | [0.65](/filings/0001206774-26-000259.md) | [0.81](/filings/0001206774-26-000404.md) | [1.07](/filings/0001206774-25-000738.md) | not reported | [1.19](/filings/0001206774-26-000259.md) | [1.20](/filings/0001206774-26-000404.md) |
| Free cash flow | $m | [26.1 d](/filings/0001206774-25-000738.md) | [(2.0) d](/filings/0001206774-26-000084.md) | [7.4](/filings/0001206774-26-000259.md) | [10.4 d](/filings/0001206774-26-000404.md) | [14.4 d](/filings/0001206774-25-000738.md) | [(2.4) d](/filings/0001206774-26-000084.md) | [10.5](/filings/0001206774-26-000259.md) | [16.7 d](/filings/0001206774-26-000404.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.4](/filings/0001206774-24-000233.md) | [4.2](/filings/0001206774-25-000099.md) | [4.0](/filings/0001206774-26-000084.md) | [5.6](/filings/0001206774-26-000084.md) | [6.3](/filings/0001206774-26-000084.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [410.6%](/filings/0001206774-24-000233.md) | [693.5%](/filings/0001206774-25-000099.md) | [332.7%](/filings/0001206774-26-000084.md) | [279.3%](/filings/0001206774-26-000084.md) | [483.4%](/filings/0001206774-26-000084.md) |
| Diluted EPS | $ per share | [5.85](/filings/0001206774-24-000233.md) | [3.61](/filings/0001206774-25-000099.md) | [1.66](/filings/0001206774-26-000084.md) | [1.91](/filings/0001206774-26-000084.md) | [3.72](/filings/0001206774-26-000084.md) |
| Free cash flow | $m | [51.6](/filings/0001206774-24-000233.md) | [36.4](/filings/0001206774-25-000099.md) | [16.4](/filings/0001206774-26-000084.md) | [24.8](/filings/0001206774-26-000084.md) | [29.9](/filings/0001206774-26-000084.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sfst/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [FJ Capital Management LLC](/funds/1599170.md) | 2026-06-30 | $54.5m | 892,223 |  | Added +85,000 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $50.7m | 830,375 |  | Added +117,965 |
| [ENDEAVOUR CAPITAL ADVISORS INC](/funds/1218749.md) | 2026-06-30 | $40.5m | 662,860 |  | Added +55,455 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $24.0m | 392,789 |  | Added +47,904 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $23.7m | 387,861 |  | Added +7,493 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $22.8m | 373,521 |  | Added +205,558 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $15.1m | 247,644 |  | Reduced −23,599 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $14.5m | 237,053 |  | Added +56,822 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $11.4m | 186,307 |  | Added +35,700 |
| [Walleye Capital LLC](/funds/1758720.md) | 2026-06-30 | $11.0m | 179,992 |  | New +179,992 |

## Recent filings

[All 903 filings](/companies/sfst/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 08:30 ET | [8-K](/filings/0001206774-26-000563.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001206774-26-000563 |
| 2026-08-28 | 17:42 ET | [8-K](/filings/0001206774-26-000469.md) | 8.01 Other events | 0001206774-26-000469 |
| 2026-08-03 | 13:09 ET | [10-Q](/filings/0001206774-26-000404.md) | Quarterly report, period 2026-06-30 | 0001206774-26-000404 |
| 2026-07-21 | 08:30 ET | [8-K](/filings/0001206774-26-000359.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001206774-26-000359 |
| 2026-06-02 | 14:04 ET | [8-K](/filings/0001206774-26-000308.md) | 5.02 Departure or appointment of officers or directors | 0001206774-26-000308 |
| 2026-05-20 | 14:50 ET | [8-K](/filings/0001206774-26-000289.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure | 0001206774-26-000289 |
| 2026-05-01 | 09:01 ET | [10-Q](/filings/0001206774-26-000259.md) | Quarterly report, period 2026-03-31 | 0001206774-26-000259 |
| 2026-04-21 | 08:30 ET | [8-K](/filings/0001206774-26-000230.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001206774-26-000230 |
| 2026-04-16 | 09:26 ET | [8-K](/filings/0001206774-26-000226.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001206774-26-000226 |
| 2026-04-15 | 16:15 ET | [8-K](/filings/0001206774-26-000221.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001206774-26-000221 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001206774-26-000084.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1090009
- Tickers: SFST
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: SC
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:53 ET. No prices; not investment advice.